[O-17] Oral Session 17 Neuromuscular junction disorders

[O-17-3] The association serum level of soluble co-stimulatory molecules and clinical status in MG patients

^○Hiroyuki Akamine¹, Akiyuki Uzawa¹, Yuta Kojima¹, Yukiko Ozawa¹, Manato Yasuda¹, Yosuke Onishi¹, Naoki Kawaguchi², Keiichi Himuro³, Satoshi Kuwabara¹ (1.Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan, 2.Department of Neurology, Dowa Institute of Clinical Neuroscience, Neurology Clinic Chiba, Chiba, Japan, 3.Department of Neurology, Matsudo Neurology Clinic, Chiba, Japan)